At Swiss Medica, parents observe changes in: Learning readiness: ability to focus, shift attention, and stay with an activity Communication attempts: use of words, AAC devices, gestures, or eye contact Emotional regulation: frequency and intensity of meltdowns, recovery time Sleep patterns: time needed to fall asleep, night waking Participation in routines: engagement in meals, play, school tasks, and self-care In our clinical practice, we observe these improvements in approximately 80% of patients , ranging from minor changes to more significant outcomes
The qPCR was performed using PerfeCTa SYBR Green SuperMix (Quantabio) conducted on an ABI StepOne Real-Time System following the cycles: 95 C for 3 min and 40 cycles of 95 C for 10 s and 60 C for 30 s
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
By the time I got in my car, I had to turn around and come back home
